Dechra Veterinary Products
Following the acquisition of VetXX in January 2008, Dechra Veterinary Products now operates in ten European countries (Denmark, Finland, France, Ireland, Netherlands, Norway, Portugal , Spain, Sweden and the UK) as well as in the US. In addition we work with partners to distribute our products in other key markets throughout the world.
The company's product portfolio is focused on providing therapeutic solutions for the care of companion animals. The key areas of expertise span dermatology, endocrinology, equine medicine, ophthalmology and critical care. The leading branded pharmaceuticals for companion animals include Vetoryl® Capsules, for the treatment of canine hyperadrenocorticism (Cushing's syndrome); Felimazole® Tablets, for treating feline hyperthyroidism and Equipalazone®, the market-leading anti-inflammatory and analgesic for equine musculoskeletal disorders. The recent additions of the SPECIFIC® dog and cat diet range, the ophthalmic product Fucithalmic® Vet and the dermatology brands Canaural®, Fuciderm® Gel and Malaseb® Shampoo further strengthen Dechra's product portfolio
website: www.dechra.com